Fundraising Fox

Michael Aberman

Investor

Dr. at Cure Ventures

About

Associated with portfolio company XenImmune, which targets tumors by leveraging the immune response.

Colleagues at Cure Ventures

Albert J. Robichaud
Partner at Cure Ventures
Annie Mitsak
Partner at Cure Ventures
Bill Amsbaugh
CTO and Partner at Cure Ventures
Courtney Turner
Director of Finance at Cure Ventures
David Fallace
Managing Partner at Cure Ventures
Dr. Michael Aberman
Investor at Cure Ventures
Dr. Milenko Cicmil
Investor at Cure Ventures
Drew King
CFO and Partner at Cure Ventures